Press-release for stocks related to therapeutics

Prices are updated after-hours

tags : Therapeutics crawled date : 2022 - 03 - 31

save search

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-03-31 (Crawled : 23:00) - globenewswire.com
SRPT | $124.27 6.11% 5.75% 1.3M

Health Technology

| 49.92% | O: 0.38% H: 5.42% C: 5.28%
nasdaq therapeutics granted grant

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
Published: 2022-03-31 (Crawled : 22:00) - biospace.com/
SLNO | $39.365 -1.93% -1.97% 340K

Health Technology

| 18338.22% | O: 6.11% H: 0.04% C: -3.46%
therapeutics results

TransCode Therapeutics Reports 2021 Results; Provides Business UpdateCompany to host investor update call Thursday, April 7, at 4:30 p.m. ET
Published: 2022-03-31 (Crawled : 22:00) - biospace.com/
RNAZ | $0.452 -1.72% -1.75% 91K

Professional, Scientific, and T...

| -99.16% | O: -1.1% H: 8.52% C: 6.67%
therapeutics

Finch Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Published: 2022-03-31 (Crawled : 21:00) - globenewswire.com
FNCH | $2.305 -17.35% -20.99% 120K

Professional, Scientific, and T...

| -44.53% | O: -0.6% H: 3.2% C: -5.6%
therapeutics results

Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates
Published: 2022-03-31 (Crawled : 17:00) - biospace.com/
WINT | $5.085 -10.53% -11.77% 51K

Health Technology

| 389.66% | O: -0.86% H: 1.74% C: -0.87%
therapeutics results

HighTide Therapeutics Appoints Myleen Leoncavallo as SVP Regulatory Affairs and Quality Assurance
Published: 2022-03-31 (Crawled : 17:00) - biospace.com/
MIRM | $24.0 -1.72% -1.75% 320K

Health Technology

| 11.25% | O: -0.36% H: 1.23% C: 0.69%
therapeutics

Jasper Therapeutics to Present Updated Data on JSP191 Conditioning in SCID Patients at the 2022 Clinical Immunology Society Annual Meeting
Published: 2022-03-31 (Crawled : 16:00) - biospace.com/
JSPR | $22.08 -0.14% -0.14% 45K

| 560.0% | O: 2.69% H: 7.27% C: 3.2%
jsp191 immunology therapeutics

Cidara Therapeutics Announces the Completion of Dosing the First Cohort of Healthy Volunteers in the Phase 1 Trial of CD388 in Development for Universal Prevention and Treatment of Seasonal and Pandemic Influenza
Published: 2022-03-31 (Crawled : 16:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -15.98% | O: 0.8% H: 0.0% C: 0.0%
CDTX | News | $11.94 16.49% 14.15% 170K

Health Technology

| -38.94% | O: 1.77% H: 1.56% C: -2.04%
cd388 treatment trial therapeutics influenza phase 1

Acer Therapeutics Regains Compliance with Nasdaq Listing Standard
Published: 2022-03-31 (Crawled : 13:20) - biospace.com/
ACER | $0.9 -3.61% 420K

Health Technology

| -68.97% | O: -1.72% H: 4.91% C: 1.75%
nasdaq therapeutics

Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call Call Scheduled for Today, Thursday, March 31, 2022 at 5:00 pm ET
Published: 2022-03-31 (Crawled : 13:20) - biospace.com/
VVOS | $2.58 -2.64% -2.71% 75K

Health Technology

| 0.0% | O: 8.68% H: 0.0% C: -6.94%
conference therapeutics results

Tenax Therapeutics Reports Fiscal Year 2021 Results and Provides Business Update
Published: 2022-03-31 (Crawled : 13:20) - biospace.com/
TENX | $3.51 0.29% 0.28% 7.9K

Health Technology

| 321.69% | O: 2.17% H: 0.0% C: -4.53%
therapeutics results

Sigyn Therapeutics Appoints Ajay Verma, M.D., Ph.D. to its Scientific Advisory Board
Published: 2022-03-31 (Crawled : 13:00) - biospace.com/
SIGY | $0.15 -1.53% 47K

| Email alert Add to watchlist
therapeutics

Agile Therapeutics® Announces First Twirla® Commercial Targeting Gen Z
Published: 2022-03-31 (Crawled : 12:20) - biospace.com/
AGRX | $0.37 0.0% 95K

Health Technology

| 54.23% | O: -4.13% H: 1.0% C: -8.91%
therapeutics twirla transdermal system contraceptive commercialization

Ventus Therapeutics Appoints Christine Ha as Chief Financial Officer
Published: 2022-03-31 (Crawled : 12:20) - biospace.com/
MS | News | $93.85 0.1% 0.0% 4.8M

Finance

| 2.17% | O: -2.24% H: 0.0% C: 0.0%
therapeutics

Abeona Therapeutics Announces Strategy Update and 2021 Financial Results
Published: 2022-03-31 (Crawled : 12:20) - biospace.com/
ATXI | $0.0949 -29.18% -41.2% 12M

Health Technology

| -98.31% | O: -2.69% H: 4.72% C: -3.7%
ABEO | News | $3.165 -7.19% -7.74% 2.2M

Health Technology

| 1012.2% | O: -4.96% H: 13.25% C: 8.1%
therapeutics results

Outlook Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for ONS-5010 as a Treatment for Wet AMD
Published: 2022-03-31 (Crawled : 12:20) - globenewswire.com
OTLK | News P | $8.2 0.0% 240K

Health Technology

| 312.06% | O: 0.0% H: 1.51% C: -10.55%
ons-5010 treatment drug application license therapeutics food

Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call
Published: 2022-03-31 (Crawled : 12:20) - globenewswire.com
VVOS | $2.58 -2.64% -2.71% 75K

Health Technology

| 0.0% | O: 8.68% H: 0.0% C: -6.94%
conference therapeutics results

Autolus Therapeutics Receives EMA Orphan Medical Product Designation for obe-cel for Treatment of Acute Lymphoblastic Leukemia
Published: 2022-03-31 (Crawled : 12:00) - biospace.com/
AUTL | $4.23 -5.58% -5.91% 2.7M

Health Technology

| 5.91% | O: 0.24% H: 0.0% C: -1.65%
treatment ema leukemia therapeutics designation

Eikon Therapeutics Announces the Election of Kenneth C. Frazier to Its Board of Directors
Published: 2022-03-31 (Crawled : 12:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M

Health Technology

| 53.98% | O: 0.61% H: 0.57% C: -1.03%
XOM | $121.05 0.02% -0.05% 12M

Energy Minerals

| 43.02% | O: -1.09% H: 1.85% C: -0.34%
therapeutics

Cerevel Therapeutics Announces Upcoming Presentations at AAN 2022
Published: 2022-03-31 (Crawled : 11:00) - globenewswire.com
CERE | $41.87 -0.29% -0.29% 630K

Finance

| 24.9% | O: 1.34% H: 6.06% C: 2.76%
therapeutics